11:10:11 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2025-06-25 Årsstämma 2025
2025-03-05 Bokslutskommuniké 2024
2024-11-27 Kvartalsrapport 2024-Q3
2024-09-25 Kvartalsrapport 2024-Q2
2024-06-27 Ordinarie utdelning SOFTX 0.00 NOK
2024-06-26 Årsstämma 2024
2024-05-29 Kvartalsrapport 2024-Q1
2024-03-27 Extra Bolagsstämma 2024
2024-03-20 Bokslutskommuniké 2023
2023-10-26 Kvartalsrapport 2023-Q3
2023-09-26 Kvartalsrapport 2023-Q2
2023-06-21 Årsstämma 2023
2023-06-21 Kvartalsrapport 2023-Q1
2023-03-30 Ordinarie utdelning SOFTX 0.00 NOK
2023-02-17 Bokslutskommuniké 2022
2022-12-09 Extra Bolagsstämma 2022
2022-10-26 Kvartalsrapport 2022-Q3
2022-08-15 Kvartalsrapport 2022-Q2
2022-04-28 Kvartalsrapport 2022-Q1
2022-04-19 Ordinarie utdelning SOFTX 0.00 NOK
2022-04-17 Årsstämma 2022
2022-02-16 Bokslutskommuniké 2021
2021-12-29 Extra Bolagsstämma 2021
2021-11-17 Kvartalsrapport 2021-Q3
2021-09-08 Kvartalsrapport 2021-Q2
2021-04-29 Kvartalsrapport 2021-Q1
2021-04-14 Ordinarie utdelning SOFTX 0.00 NOK
2021-04-13 Årsstämma 2021
2021-02-09 Bokslutskommuniké 2020
2020-12-14 Kvartalsrapport 2020-Q3
2020-09-30 Kvartalsrapport 2020-Q2
2020-07-01 Ordinarie utdelning SOFTX 0.00 NOK
2020-06-30 Kvartalsrapport 2020-Q1
2020-06-30 Årsstämma 2020
2019-12-20 Extra Bolagsstämma 2019
2019-06-27 Årsstämma 2019
2019-06-03 Ordinarie utdelning SOFTX 0.00 NOK
2018-07-02 Split SOFTX 1:50

Beskrivning

LandNorge
ListaEuronext Growth Oslo
SektorHälsovård
IndustriMedicinteknik
SoftOx Solutions är ett norskt medicintekniskt bolag. Bolaget har utvecklat en egenpatenterad lösning baserad på ättiksyra för behandling av kroniska sår hos patienter. Lösningen används för att eliminera infektioner i samband med biofilmer, vilket består av olika kluster av bakterier. En del av läkemedelsutvecklingen sker i samarbete med övriga forskningsinstitut. SoftOx Solutions etablerades under 2012 och har sitt huvudkontor i Oslo, Norge.
2021-08-31 09:58:09
Sykehusinnkjøp HF's national tender - hygiene products, disinfectants and
dispensing solutions for hand disinfectants, soap and cream (HINAS).

SoftOx Solutions AS (SoftOx) has participated in the HINAS tender mentioned here
and reports that the company's hand disinfectant product SafeDes® has been
selected and will be listed in Norwegian hospitals as the only alternative to
alcohol-based products following the decision in the national tender.

From the evaluation for subcontract 16, hand disinfectants without alcohol
(bottles), SoftOx received a top score on the evaluation criteria "properties on
skin" and quality. The product is an alternative for those who have skin
problems related to the use of alcohol. The skin does not feel sticky or dry
after use.

This, in combination with a competitive price, is the overall evaluation that
SoftOx comes out best in the assessment.

The product has been assessed by the country's foremost professional expertise
on efficacy and safety in disinfection. This is a confirmation of our base
technology, and the decision clearly shows that the product has a place in the
health care system. "Winning a national hospital tender is also a very important
reference for the company in other markets, in addition to being a confirmation
of our research and our work so far. This award shows that our commitment to
health has been right and provides a good basis for further investment," says
CEO Geir Almås.

The company announces increased investment in its disinfection products. Based
on the clear advantages of the products: skin friendliness, effect and security,
we will continue to invest in the categories defense, health, B2B and the
transportation industry. We now see that the market responds within these
categories and are experiencing increased demand and sales. However, the
Norwegian hospital market is the company's pilot customer and is not expected to
provide profitability during the first years.

With reference to the stock exchange announcement on 2 July 2021, the company is
still working on the basis that company will enter a transitional arrangement in
the connection with the new biocidal regulations.

Further information, please contact:
Geir Almås, CEO of SoftOx Solutions AS, or
Mail: ir@soft-ox.com
Phone: Front Desk: (+47) 948-59-599

About SoftOx Solutions AS
SoftOx Solutions AS is a Norwegian BioTech company listed on Euronext Growth
Oslo. Our vision is "Helping the world fighting infections - developing new ways
of eradicating infections and fighting antimicrobial resistance". We are working
to combat major threats to human health, namely the emergence of antimicrobial
resistance (AMR), biofilm infections in chronic wounds and the spread of
viruses. For more information on SoftOx, visit www.soft-ox.com.